Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial-Reference-Cited by-同舟云学术

Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial

Published:2011-11 Issue: Volume: Page:no-no
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:

Author:

Bissonnette R.,Bolduc C.,Maari C.,Nigen S.,Webster J.M.,Tang L.,Lyle M.

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-3083.2011.04332.x/fullpdf

Reference9 articles.

1. Treatment of psoriasis;Greaves;N Engl J Med,1995

2. Topical treatment in psoriasis: today and tomorrow;Bos;Clin Dermatol,2008

3. Psoriasis: emerging therapeutic strategies;Gottlieb;Nat Rev Drug Discov,2005

4. Pathogenesis and therapy of psoriasis;Lowes;Nature,2007

5. Welichem Biotech Inc

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double‐blinded clinical trial;Skin Research and Technology;2024-04

2. The Role of Aryl Hydrocarbon Receptor in the Pathogenesis and Treatment of Psoriasis;Journal of Cutaneous Medicine and Surgery;2024-03-18

3. Treatment of chronic plaque psoriasis: An overview on current update;Pharmacological Research - Reports;2024-03

4. New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis;Pharmaceutics;2024-02-06

5. Novel effect of topical Roquinimex and its combination with Clobetasol on an imiquimod-induced model of psoriasis in mice;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-24